Cargando…
Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab
BACKGROUND: This study examines the dynamics of the eculizumab patenting, orphan designation, and marketing authorization process in different countries and regulatory systems and analyzes drug revenues since its first marketing authorization. METHODS: A retrospective case study was conducted. Multi...
Autores principales: | Caetano, Rosângela, Cordeiro Dias Villela Correa, Marilena, Villardi, Pedro, Almeida Rodrigues, Paulo Henrique, Garcia Serpa Osorio-de-Castro, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935269/ https://www.ncbi.nlm.nih.gov/pubmed/33667235 http://dx.doi.org/10.1371/journal.pone.0247853 |
Ejemplares similares
-
The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health
por: Caetano, Rosângela, et al.
Publicado: (2020) -
Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019) -
The Legislative Approach and System Improvement of China’s Compulsory Licensing for Drug Patents
por: Cao, Zhang, et al.
Publicado: (2021) -
Registries for orphan drugs: generating evidence or marketing tools?
por: Hollak, Carla E. M., et al.
Publicado: (2020) -
Disentangling the Cost of Orphan Drugs Marketed in the United States
por: Althobaiti, Hana, et al.
Publicado: (2023)